SGLT2i, GLP-1 RA Prescribing Lower for Minority Patients

WEDNESDAY, March 20, 2024 -- Pharmacy dispensing patterns for sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide 1 receptor agonist (GLP1-RA) medications show lower prescribing for minority patients; and the rate of SGLT2i...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Sodium